New products and changes introduced over the last week include a short-term emerging markets bond ETF from ProShares; an S&P 500-based ETF in China; and an annuity from Allianz Life with a 7-year decreasing surrender charge.
In addition, W.E, Donoghue launched a power dividend index fund; American Century offered a retirement plan assessment tool; and Franklin Templeton and K2 Advisors announced a multi-strategy fund.
Here are the latest developments of interest to advisors:
1) ProShares Launches Short-Term Emerging Market Bond ETF
Proshares announced Thursday the launch of the Short Term USD Emerging Markets Bond ETF (EMSH), which is designed to offer yield potential with reduced interest rate sensitivity.
EMSH tracks the DBIQ Short Duration Emerging Market Bond Index, which is composed of a diversified portfolio of U.S. dollar-denominated emerging markets bonds with a weighted average maturity of three years or less. The index currently includes bonds from 19 countries issued by sovereign governments, other government entities and agencies, as well as corporations that have significant government ownership. A country’s weight in the index is capped at 10%. Bonds must have a minimum $500 million outstanding issuance to be eligible.
Top 10 Paper Companies To Own In Right Now: Aspen Insurance Holdings Ltd (AHL)
Aspen Insurance Holdings Limited (Aspen Holdings), incorporated on May 23, 2002, is a holding company. The Company conducts insurance and reinsurance business through its subsidiaries in three jurisdictions: Aspen Insurance UK Limited (Aspen U.K.) and Aspen Underwriting Limited (AUL), corporate member of Syndicate 4711 at Lloyd�� of London (United Kingdom), Aspen Bermuda Limited (Aspen Bermuda) and Aspen Specialty Insurance Company (Aspen Specialty) and Aspen American Insurance Company (AAIC). Aspen U.K. also has branches in Paris (France), Zurich (Switzerland), Dublin (Ireland), Cologne (Germany), Singapore, Australia and Canada. It operates in the global markets for property and casualty insurance and reinsurance. It manages its insurance and reinsurance businesses as two distinct underwriting segments, Aspen Insurance and Aspen Reinsurance (Aspen Re), to serve its global customer base. Its insurance segment is consisted of property, casualty, marine, energy and transportation insurance and financial and professional lines insurance. Its reinsurance segment is consisted of property reinsurance (catastrophe and other), casualty reinsurance and specialty reinsurance. In April 2013, the reinsurance segment of the Company announced the formation of a new division, Aspen Capital Markets.
In the Company�� insurance segment, property, casualty and financial and professional lines insurance business is written in the London Market through Aspen U.K. and in the United States through Aspen Specialty and AAIC. Its marine, energy and transportation insurance business is written through Aspen U.K. and AUL, which is the corporate member of Syndicate 4711 at Lloyd�� of London (Lloyd��), managed by Aspen Managing Agency Limited (AMAL). It also writes casualty business through AUL. In reinsurance, property reinsurance business is assumed by Aspen Bermuda and Aspen U.K. The property reinsurance business written in the United States is written by Aspen Re America and ARA-CA as reinsurance intermed! iaries with offices in Connecticut, Illinois, Florida, New York, Georgia and California. The business written in the United States is produced by Aspen Re America.
Reinsurance
The Company�� reinsurance segment consists of property catastrophe reinsurance, other property reinsurance (risk excess, pro rata, risk solutions and facultative), casualty reinsurance (the United States treaty, international treaty and global facultative) and specialty reinsurance (credit and surety, structured, agriculture and specialty). Property catastrophe reinsurance is written on a treaty excess of loss basis where it provides protection to an insurer for an agreed portion of the total losses from a single event in excess of a specified loss amount. In the event of a loss, contracts provide for coverage of a second occurrence following the payment of a premium to reinstate the coverage under the contract, which is referred to as a reinstatement premium. The coverage provided under excess of loss reinsurance contracts may be on a global basis or limited in scope to selected regions or geographical areas.
Other property reinsurance includes risk excess of loss and proportional treaty reinsurance, facultative or single risk reinsurance and its risk solutions business. Risk excess of loss reinsurance provides coverage to a reinsured where it experiences a loss in excess of its retention level on a single risk basis. Proportional contracts involve close client relationships, including regular audits of the cedants��data. Its risk solutions business writes property insurance risks for a select group of the United States program managers. Casualty reinsurance is written on an excess of loss, proportional and facultative basis and consists of the United States treaty, international treaty and casualty facultative. Its United States treaty business consists of exposures to workers��compensation (including catastrophe), medical malpractice, general liability, auto liability, professional l! iability ! and excess liability, including umbrella liability. Its international treaty business reinsures exposures respect to general liability, auto liability, professional liability, workers��compensation and excess liability.
Specialty reinsurance is written on an excess of loss and proportional basis and consists of credit and surety reinsurance, structured risks, agriculture reinsurance and other specialty lines. Its credit and surety reinsurance business consists of trade credit reinsurance, international surety reinsurance (mainly European, Japanese and Latin American risks and excluding the United States) and a political risks portfolio. Its agricultural reinsurance business is written on a treaty basis covering crop and multi-peril business. Other specialty lines include reinsurance treaties and some insurance policies covering policyholders��interests in marine, energy, liability aviation, space, contingency, terrorism, nuclear, personal accident and crop reinsurance. A percentage of the property reinsurance contracts it writes exclude coverage for losses arising from the peril of terrorism. These contracts exclude coverage protecting against nuclear, biological or chemical attack.
The Company competes Arch Capital Group Ltd., Axis Capital Holdings Limited (Axis), Endurance Specialty Holdings Ltd. (Endurance), Everest Re Group Limited, Lancashire Holdings Limited, Montpelier Re Holdings Limited, PartnerRe Ltd., Platinum Underwriters Holdings Ltd., Renaissance Re Holdings Ltd., Validus Holdings Ltd., XL Capital Ltd. (XL) and various Lloyd�� syndicates.
Insurance
The Company�� insurance segment consists of property insurance, casualty insurance, marine, energy and transportation insurance and financial and professional lines insurance. Its property insurance line comprises the United Kingdom commercial property and construction business and the United States property business. Property insurance provides physical damage and business interruption! coverage! for losses arising from weather, fire, theft and other causes. The United States commercial property team covers mercantile, manufacturing, municipal and commercial real estate business. The United States property also includes its program business, which writes property insurance risks for a select group of the United States program managers. The United Kingdom commercial team�� client base is predominantly the United Kingdom institutional property owners, middle market corporates and public sector clients.
The Company�� casualty insurance line comprises commercial liability, global excess casualty, the United States casualty insurance and environmental liability, written on a primary, quota share and facultative basis. Commercial liability is written in the United Kingdom and provides employers��liability coverage and public liability coverage for insureds domiciled in the United Kingdom and Ireland. The global excess casualty line comprises risk-managed insureds globally and covers risks at points, including general liability, commercial and residential construction liability, life science, railroads, trucking, product and public liability and associated types of cover found in general liability policies in the global insurance market. The United States casualty account consists of lines written within the general liability and umbrella liability insurance sectors. Coverage on its general liability line is offered on those risks that are miscellaneous, products liability, contractors (general contractors and artisans), real estate and retail risks and other general liability business. The United States environmental account provides contractors��pollution liability and pollution legal liability across industry segments that have environmental regulatory drivers and contractual requirements for coverage, including real estate and public entities, contractors and engineers, energy contractors and environmental contractors and consultants. The business is written in both the primar! y and exc! ess insurance markets.
The Company�� marine, energy and transportation insurance line comprises marine, energy and construction (M.E.C.) liability, energy physical damage, marine hull, specie, inland marine and ocean risks and aviation, written on a primary, quota share and facultative basis. The M.E.C. liability business includes marine liability cover related to the liabilities of ship-owners and port operators, including reinsurance of Protection and Indemnity Clubs (P&I Clubs). It also provides liability cover for companies in the oil and gas sector, both onshore and offshore and in the power generation and the United States commercial construction sectors. Energy physical damage provides insurance cover against physical damage losses in addition to Operators Extra Expenses (OEE) for companies operating in the oil and gas exploration and production sector. The marine hull team insures physical damage for ships (including war and associated perils) and related marine assets. The specie business line focuses on the insurance of property items on an all risks basis, including fine art, general and bank related specie, jewelers��block and armored car. The inland marine and ocean cargo team writes business covering builders��construction risk, contractors��equipment, transportation and ocean cargo risks in addition to exhibition, fine arts and museums insurance.
The aviation team writes physical damage insurance on hulls and spares (including war and associated perils) and comprehensive legal liability for airlines, smaller operators of airline equipment, airports and associated business and non-critical component part manufacturers. It also provides aviation hull deductible cover. Its financial and professional lines comprise financial institutions, professional liability (including management and technology liability), financial and political risks and the United States surety risks, written on a primary, quota share and facultative basis. Its financial institutions ! business ! is written on both a primary and excess of loss basis and consists of professional liability, crime insurance and directors��and officers��(D&O) cover. It covers financial institutions, including commercial and investment banks, asset managers, insurance companies, stockbrokers and insureds with hybrid business models. Its professional liability business is written out of the United States (including Errors and Omissions (E&O)), the United Kingdom and Switzerland and is written on both a primary and excess of loss basis.
The Company insures a range of professions, including lawyers, accountants, architects and engineers. Its management and technology liability teams write on both a primary and excess basis D&O insurance, technology-related policies in the areas of network privacy, misuse of data and cyber liability and warranty and indemnity insurance in connection with, or to facilitate, corporate transactions. The financial and political risks team writes business covering the credit/default risk on a range of project and trade transactions, as well as political risks, terrorism (including multi-year war on land cover), piracy and kidnap and ransom (K&R). It writes financial and political risks globally but with concentrations in a range of countries, such as Russia, China, Brazil, the Netherlands and United States. Its surety team writes commercial surety risks, admiralty bonds and similar maritime undertakings, including federal and public official bonds, license and permits and fiduciary and miscellaneous bonds and privately owned companies in the United States.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading UP
Aspen Insurance Holdings (NYSE: AHL) shares shot up 11.05 percent to $43.72 after Endurance Specialty Holdings (NYSE: ENH) offered to buy Aspen Insurance for $47.50 per share in a cash and stock deal. - [By Jake L'Ecuyer]
Equities Trading UP
Aspen Insurance Holdings (NYSE: AHL) shares shot up 11.33 percent to $43.83 after Endurance Specialty Holdings (NYSE: ENH) offered to buy Aspen Insurance for $47.50 per share in a cash and stock deal. - [By Anna Prior]
Aspen Insurance Holdings Ltd.(AHL) said it expects second-quarter operating earnings above Wall Street projections, citing “the continued excellent performance across our businesses.”
- [By Sally Jones] % over 12 months, Aspen Insurance Holdings Ltd. has a market cap of $2.63 billion; its shares were traded at around $40.06 with a P/E ratio of 13.50. The dividend yield is 1.80%.
The GuruFocus analysis for AHL shows six warning signs.
Track historical share pricing, revenue and net income:
[ Enlarge Image ]
Guru Action: As of Sept. 30, 2013, Arnold Schneider reduced his position by 89.42%, selling 109,081 shares at an average price of $36.77, for a gain of 8.9%.
Over five quarters, Schneider has averaged a 28% gain on 166,209 shares bought at an average price of $31.34 per share. He gained 8% selling 153,305 shares at an average price of $37.03 per share.
Guru Action: As of Sept. 30, 2013, Jim Simons increased his position by 387.47%, buying 501,000 shares at an average price of $36.77, for a gain of 8.9%. His current shares are 630,300.
Over five years, Simons has sold out three times. He has averaged a 15% gain on 876,900 shares bought at an average price of $34.82 per share. He gained 13% on 246,600 shares sold at an average price of $35.35 per share.
Guru Action: As of Sept. 30, 2013, Steven Cohen increased his position by 190.15%, buying 15,037 shares at an average price of $36.77, for a gain of 8.9%. His current shares are 22,945.
Cohen has averaged an 18% gain on 36,658 shares bought at an average price of $33.98 per share. He gained 22% on 13,713 shares sold at an average price of $32.85 per share.
Guru Action: As of Sept. 30, 2013, top guru stakeholder David Einhorn reduced his position by 36.93%, selling 1,451,581 shares at an average price of $36.77, for a gain of 8.6%. This trade impacts his portfolio by -1%. His current shares are 2,478,935 or 3.67% of shares outstanding.
Over five years, Einhorn has averaged a 67% gain on 5,700,182 shares bought at an average price of $23.88 per share. He gained 15% on 3,221,247 shares sold at an average price of $34.57 per share.
Here�
Top 5 Healthcare Equipment Stocks To Invest In Right Now: Micromem Technologies Inc (MMTIF)
Micromem Technologies Inc. (Micromem), incorporated on October 21, 1985, is a development-stage company. The Company is engaged in the development of memory technology that has the characteristics of non-volatility, which is the ability to retain information after power has been shut off. The Company is focused on magnetic sensor applications. The Company is focused on research and development of nano-magnetic random access memory (MRAM). Micromem operates in a single segment as a developer of non-volatile magnetic memory and sensor technology. The Company partners with industry to manufacture.
The Company�� technology is based on the ability to use magnetic materials in combination with a sensor to record the state of magnetization. Each magnetic element stores one bit of data based on its ability to alternate between states of magnetic polarization, which states are determined by a sensor.
The Company competes with IBM.
Advisors' Opinion:- [By Peter Graham]
At the end of last week, small cap stocks Senesco Technologies, Inc (OTCBB: SNTI), VolitionRX Ltd (OTCMKTS: VNRX) and Micromem Technologies Inc (OTCBB: MMTIF) were all trending upwards ��ending up 13.65%, 8.73% and 7.61%, respectively, on Friday. However, it�� a new trading week with the last two trading days for the year. So what direction will these three small caps head in for the end of this year and into next year? Here is a quick look to help you decide on a trading or investment strategy:
Top 5 Healthcare Equipment Stocks To Invest In Right Now: Cutwater Select Income Fund (CSI)
Rivus Bond Fund (the Fund), formerly known as 1838 Bond-Debenture Trading Fund, is a diversified closed-end management investment company. The primary objective of the Fund is to maintain high level of income. Its portfolio includes long-term debt securities, including mortgage-backed securities and asset-backed securities. Effective July 7, 2006, the 1838 Bond-Debenture Trading Fund merged with and into the Rivus Bond Fund.
The Fund invests in various sectors, including automotive, chemicals, diversified financial services, energy, insurance, media, mining, real estate investment trusts, telecommunications, utilities and transportation. MBIA Capital Management Corp. serves as the investment advisor of the Fund.
Advisors' Opinion:- [By Sold At The Top]
Today's release of the S&P/Case-Shiller (CSI) home price indices for August reported that the non-seasonally adjusted Composite-10 price index rose a notable 1.33% since July while the Composite-20 index also increased 1.32% over the same period.
Top 5 Healthcare Equipment Stocks To Invest In Right Now: Neurocrine Biosciences Inc.(NBIX)
Neurocrine Biosciences, Inc. engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. It develops drugs for endometriosis, stress-related disorders, pain, tardive dyskinesia, uterine fibroids, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. The company?s products in clinical development include Elagolix, a Phase II drug for endometriosis; Vesicular Monoamine Transporter 2 Inhibitor (VMAT2), a Phase II drug for movement disorders; CRF2 Peptide Agonist, a Phase II drug for cardiovascular diseases; CRF1 Antagonist, a Phase II drug for stress-related disorders; and Elagolix, a Phase II drug for uterine fibroids. Its research programs comprise G Protein-Coupled Receptor 119 (GPR119) for type II diabetes; VMAT2 for schizophrenia; GnRH Antagonists for men?s and women?s health, and oncology; Antiepileptic Drugs for epilepsy, essential tremor, and pain; and G Protein-Coupled Receptors for other conditions. The company has collaborations with GlaxoSmithKline to develop and commercialize CRF antagonists for psychiatric, neurological, and gastrointestinal diseases; Dainippon Sumitomo Pharma Co. Ltd. to develop and commercialize Indiplon in Japan; Abbott International Luxembourg S.�r.l. to develop and commercialize elagolix and GnRH antagonists for women?s and men?s health indications; and Boehringer Ingelheim International GmbH to research, develop, and commercialize small molecule GPR119 agonists for the treatment of type II diabetes and other indications. Neurocrine Biosciences, Inc. was founded in 1992 and is headquartered in San Diego, California.
Advisors' Opinion:- [By Lauren Pollock]
Among the companies with shares expected to actively trade in Tuesday’s session are Cyan Inc.(CYNI), Neurocrine Biosciences Inc.(NBIX) and SandRidge Energy Inc.(SD)
- [By Roberto Pedone]
Another stock that's starting to trend within range of triggering a major breakout trade is Neurocrine Biosciences (NBIX), which discovers, develops and commercializes drugs for the treatment of neurological and endocrine-related diseases and disorders. This stock has been a hot name with bulls so far in 2013, with shares up 57%.
If you look at the chart for Neurocrine Biosciences, you'll notice that this stock recently gapped down sharply from $16.74 to below $11.50 a share with heavy downside volume flows. Following that gap down, shares of NBIX went on to continue its trend lower and the stock hit a new low of $10.42 a share. Shares of NBIX have started to rebound off that $10.42 low and it's now moving within range of triggering a major breakout trade.
Traders should now look for long-biased trades in NBIX if it manages to break out above some near-term overhead resistance levels at its 200-day moving average of $11.92 a share and above its gap down day high of $12.17 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 894,145 shares. If that breakout triggers soon, then NBIX will set up to re-fill some of its previous gap down zone from September that started at $16.74 a share. Some possible upside targets for NBIX if it gets into that gap with volume are $14 to $15 a share.
Traders can look to buy NBIX off any weakness to anticipate that breakout and simply use a stop that sits right below support at $11 a share, or below that recent low of $10.42 a share. One can also buy NBIX off strength once it takes out that breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By John Udovich]
Yesterday, small cap biopharmaceutical stock Neurocrine Biosciences, Inc (NASDAQ: NBIX) surged 89.69% after announcing positive results for its VMAT2 inhibitor NBI-98854 as a treatment for tardive dyskinesia, meaning investors late to the party or those already in should take a closer look at the stock along with its performance verses that of biotech ETFs like the iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI).
No comments:
Post a Comment